DHODH and cytomegalovirus infection: Indeed, it is promising to note that other inhibitors targeting de novo pyrimidine synthesis have been showing promise in vivo [43], and in particular leflunomide, which inhibits DHODH, is being used clinically in the treatment of BK virus infection in transplant recipients [46, 48] as well as for treating CMV infections [47].